CLINICALLY ISOLATED SYNDROME OF DEMYELINATION

Clinical trials for CLINICALLY ISOLATED SYNDROME OF DEMYELINATION explained in plain language.

Never miss a new study

Get alerted when new CLINICALLY ISOLATED SYNDROME OF DEMYELINATION trials appear

Sign up with your email to follow new studies for CLINICALLY ISOLATED SYNDROME OF DEMYELINATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Race against time: new trial attacks MS within days of first symptoms

Disease control Recruiting now

This study tests if starting a powerful MS medication called Tyruko (natalizumab) within just 14 days of a person's first MS-like symptoms leads to better nerve repair. It will involve 40 UK adults who have recently shown signs of MS. Researchers will use special brain scans to s…

Matched conditions: CLINICALLY ISOLATED SYNDROME OF DEMYELINATION

Phase: PHASE2 • Sponsor: Queen Mary University of London • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

CLINICALLY ISOLATED SYNDROME OF DEMYELINATION

Get alerted when new CLINICALLY ISOLATED SYNDROME OF DEMYELINATION trials appear

Race against time: new trial attacks MS within days of first symptoms